Although other findings indicate that a poor BrCa outcome may be associated with systemic and tissue IGFBP3 [59-61], studies on the correlation between IGFBP2 levels and disease prognosis are limited. This evidence concerns the gene IGFBP3 and invasive breast carcinoma.